18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer Academic Article uri icon

Overview

MeSH Major

  • Fluorodeoxyglucose F18
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed
  • Uterine Cervical Neoplasms

abstract

  • Pathologic validation of 18F-FDG-PET/CT imaging demonstrates little value for 18F-FDG-PET/CT in patients with early stage (FIGO stage 1a–1b1) MRI-defined lymph node negative cervical carcinoma. Since the likelihood of metastatic nodal disease is very low in women with stage 1a–1b1 cervical cancer, we believe that 18F-FDG-PET/CT should not have a role in the routine pre-treatment evaluation of these women.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s00261-014-0194-x

PubMed ID

  • 25015401

Additional Document Info

start page

  • 127

end page

  • 33

volume

  • 40

number

  • 1